CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Alexion Pharmaceuticals, Inc. Company Snapshot
Alexion Pharmaceuticals, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Alexion Pharmaceuticals with three other companies in this sector in UNITED STATES : Zoetis Inc (2020 sales of $6.68 billion of which 53% was US), Vertex Pharmaceuticals Inc ($6.21 billion of which 62% was TRIKAFTA), and Perrigo Company PLC ($5.06 billion of which 53% was CSCA).

Sales Analysis. During the first quarter of 2021, sales at Alexion Pharmaceuticals totalled $1.64 billion. This is an increase of 13.3% from the $1.44 billion in sales at the company during the first quarter of 2020. During the previous 33 quarters, sales at Alexion Pharmaceuticals have increased compared with the same quarter in the previous year. There appears to be at least some degree of seasonality in the sales at Alexion Pharmaceuticals: during 8 of the previous 9 years, sales were highest during the fourth quarter. The exception to this was during 2017, when the second quarter was the best quarter, accounting for 26% of sales (during that same year, the fourth quarter accounted for 26% of sales). During the year ended December of 2020, sales at Alexion Pharmaceuticals were $6.07 billion. This is an increase of 22.5% versus 2019, when the company's sales were $4.95 billion. This was the fifth consecutive year of sales increases at Alexion Pharmaceuticals (and since 2015, sales have increased a total of 133%). Sales of Ultomiris saw an increase that was more than double the company's growth rate: sales were up 217.7% in 2020, from $338.90 million to $1.08 billion.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Alexion Pharmaceuticals, Inc.
  Stock Performance Chart for Alexion Pharmaceuticals, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (6/18/2021): 180.69
(Figures in U.S. Dollars)
1 Week -0.5%   13 Weeks 1.7%  
4 Weeks 19.7%   52 Weeks 51.4%  
 
Alexion Pharmaceuticals, Inc. Key Data:
  Ticker: ALXN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 6,069,900,000
(Year Ending Jan 2021).
Employees: 3,837
  Currency: U.S. Dollars Market Cap: 39,914,421,000
  Fiscal Yr Ends: December Shares Outstanding: 220,900,000
  Share Type: Common Closely Held Shares: 606,861
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.